Scientists find new method to fight malaria

July 6, 2017, The Francis Crick Institute
Credit: CDC

Scientists have discovered a new way to slow down malaria infections, providing a possible new target for antimalarial drugs. The team are already working with pharmaceutical companies to use this knowledge to develop new antimalarials - an important step in the battle against drug resistant malaria.

When invade red blood , they form an internal compartment in which they replicate many times before bursting out of the cell and infecting more cells. In order to escape red blood cells, the parasites have to break through both the internal compartment and the cell membrane using various proteins and enzymes.

Scientists at the Francis Crick Institute and The London School of Hygiene & Tropical Medicine have identified a key involved in this process. Disrupting this protein reduces the efficiency of parasite escape, slowing down the rate of infection. The research, published in PLOS Pathogens was funded by Cancer Research UK, the Medical Research Council and Wellcome.

"The parasite sits in its internal compartment inside the cell, surrounded by lots of proteins, a bit like a baby surrounded by amniotic fluid," says Mike Blackman, Group Leader at the Francis Crick Institute. "We focused on the most common protein, known as SERA5, assuming that it probably has an important role since there is so much of it."

The team used genetic tools to knock out the gene responsible for producing SERA5 in malaria parasites and then took time-lapse video of the cells under a microscope. They found that the parasites broke through the membranes faster than normal but many got stuck on their way out, meaning that they were less likely to invade other red blood cells.

"Malaria parasites don't survive for long outside red blood cells, so if they get stuck on their way out, they might die before they have a chance to infect another cell," says Christine Collins, researcher at the Francis Crick Institute and first-named author of the paper. "We found that parasites lacking SERA5 were about half as efficient as normal parasites at escaping and infecting new cells."

The team are now working with GSK to see if SERA5 or one of the enzymes that it controls could be a potential target.

"Drug resistant malaria is a huge problem, so there is a real push to develop new drugs that work in a different way," says Mike. "None of the current antimalarials work by preventing the parasites from escaping , so we think that the proteins and enzymes that help the parasites break free could be valuable new targets that we can design drugs for."

The paper 'The Plasmodium falciparum pseudoprotease SERA5 regulates the kinetics and efficiency of egress from host erythrocytes' is published in PLOS Pathogens.

More information: PLOS Pathogens (2017). DOI: 10.1371/journal.ppat.1006453

Related Stories

Recommended for you

Collaboration yields possible treatment for rare neurodegenerative disorder

October 23, 2018
St. Jude Children's Research Hospital investigators have developed a new class of compounds that extended the lives and eased symptoms of mice with a progressive neurodegenerative human disorder. The findings appear today ...

Genetic flaw causes problems for many with hypothyroidism

October 23, 2018
With an estimated 120 million prescriptions filled each year, the thyroid medicine levothyroxine (marketed as Synthroid ) is one of the most popular prescription medicines in the United States. Most patients who suffer from ...

'Game changer' tuberculosis drug cures 9 in 10

October 22, 2018
A new treatment for a drug-resistant strain of tuberculosis can cure more than 90 percent of sufferers, according to a trial hailed Monday as a "game changer" in the fight against the global killer.

Consuming caffeine from coffee reduces incident rosacea

October 22, 2018
(HealthDay)—Caffeine intake from coffee is inversely associated with the risk for incident rosacea, according to a study published online Oct. 17 in JAMA Dermatology.

AI doctor could boost chance of survival for sepsis patients

October 22, 2018
Scientists have created an artificial intelligence system that could help treat patients with sepsis.

Home-based biofeedback therapy is effective option for tough-to-treat constipation

October 22, 2018
Biofeedback therapy used at home is about 70 percent effective at helping patients learn how to coordinate and relax bowel muscles and relieve one of the most difficult-to-treat types of constipation, investigators report.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.